• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Model Number CDS0701-NT
Device Problems Off-Label Use (1494); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombosis (2100); Tricuspid Valve Stenosis (2113)
Event Date 03/06/2020
Event Type  Injury  
Manufacturer Narrative
The other additional 2 mitraclips are being filed under a separate medwatch report number.The device was not returned.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.A definitive cause for the reported patient effect of tricuspid stenosis and thrombosis could not be determined.It should be noted that the intended use section of the mitraclip system, instruction for use states: ¿the mitraclip system is intended for reconstruction of the insufficient mitral valve through tissue approximation.The reported off-label use appears to be related to the use of the mitraclip device on the tricuspid valve; however, it could not be determined if using the mitraclip on the tricuspid valve caused or contributed to the reported difficulties.The reported patient effects of tricuspid stenosis and thrombosis are listed in the mitraclip system instructions for use as known possible complications associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
This is filed to report thrombosis, stenosis, treatment with medication, and prolonged hospitalization.It was reported that this was a mitraclip procedure to treat functional tricuspid regurgitation (tr) with a grade 4.On (b)(6) 2020, three clips were implanted for off label-use, reducing tr to <1.The next day, imaging revealed thrombosis on the anterior septal region and possibly to the posterior septal region, indicating the thrombosis is across all three clips (00107u222, 91106u225, 91106u244).Additionally, the mean pressure gradient increased to 6mmhg.The stenosis was not treated since the patient did not experience any clinical symptoms.However, blood thinners were administered to the patient in an attempt to treat the thrombosis.The patient will remain hospitalized until the thrombosis is resolved.There was no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was not returned.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on the information reviewed, a definitive cause for the reported patient effect of tricuspid stenosis and thrombosis could not be determined.It was reported that the procedure was used to treat the tricuspid valve.It should be noted that the intended use section of the mitraclip system instruction for use (ifu) states: ¿the mitraclip system is intended for reconstruction of the insufficient mitral valve through tissue approximation.Since, the device was used for a tricuspid valve procedure, this is considered as an off-label use of the device.However, it could not be determined if using the mitraclip on the tricuspid valve caused or contributed to the reported difficulties.The reported patient effect of thrombosis is listed in the mitraclip system ifu as a known possible complication associated with mitraclip procedures.Although a conclusive cause for the reported patient effects and the relationship to the device, if any, cannot be determined, there is no indication of a product quality issue with respect to manufacture, design or labeling.Added a conclusion code removed statement, the reported patient effects of tricuspid stenosis and thrombosis are listed in the mitraclip system instructions for use as known possible complications associated with mitraclip procedures.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9898425
MDR Text Key188558630
Report Number2024168-2020-03095
Device Sequence Number1
Product Code NKM
UDI-Device Identifier08717648230943
UDI-Public08717648230943
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/06/2020
Device Model NumberCDS0701-NT
Device Catalogue NumberCDS0701-NT
Device Lot Number91106U244
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/10/2020
Initial Date FDA Received03/30/2020
Supplement Dates Manufacturer Received04/06/2020
Supplement Dates FDA Received04/09/2020
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
Treatment
2 IMPLANTED MITRACLIPS
Patient Outcome(s) Hospitalization; Other; Required Intervention;
-
-